[1]
“Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review”, Reumatismo, vol. 77, no. 1, Oct. 2024, doi: 10.4081/reumatismo.2024.1686.